Universal Detection Technology Presents Live Training Demos Of Anthrax Detection Kits At Milipol Paris 2009
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009. Universal Detection Technology's kits, certified earlier this year by the U. ...more
12 Nov 2009
UIC To Develop Antibiotics Against Potential Bioterrorism Agents
Researchers at the University of Illinois at Chicago have received a $4 million federal grant to develop new antibiotics to treat anthrax, tularemia and plague. Anthrax, tularemia and plague are caused by naturally occurring bacteria classified as "category-A" agents that could be used in bioterrorism and biowarfare. ...more
11 Nov 2009
New Human Immunology Research Awards To Help Fight Emerging Infectious Diseases Announced By NIAID
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism. ...more
10 Nov 2009
Universal Detection Technology Mold Detection Device To Protect Homeowners From Toxic Black Mold In Flood-Damaged Homes
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced today that it is expanding its product catalogue to include a consumer-ready kit for the detection of black mold. The lethal toxin can make homes in areas of high humidity or flood-damaged homes inhabitable and cause serious health complications. ...more
05 Nov 2009
Asthma Plagues World Trade Center Responders
Responders to the 2001 World Trade Center (WTC) terrorist attacks, who were exposed to caustic dust and toxic pollutants following the 9/11 disaster, suffer from asthma at a rate more than twice that of the general US population, according to new research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP). ...more
04 Nov 2009
Improved Healing Of Bone Fractures After Radiation Exposure
A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. The study's results were presented during the American Society for Radiation Oncology (ASTRO) annual meeting in Chicago. The drug, JP4-039, is a free-radical scavenger targeted to the mitochondria, the energy generator of all cells. ...more
EPSRC-Funded Research Develops Advanced Sensors For Detection Of Chemicals And Illegal Drugs
Scientists at Queen's University Belfast are developing new sensors to detect chemical agents and illegal drugs which will help in the fight against the threat of terrorist attacks. The devices will use special gel pads to 'swipe' an individual or crime scene to gather a sample which is then analysed by a scanning instrument that can detect the presence of chemicals within seconds. This will allow better, faster decisions to be made in response to terrorist threats. ...more
07 Oct 2009
NIAID To Fund Development Of Emergent BioSolutions' Advanced Anthrax Vaccine Candidate
Emergent BioSolutions Inc. (NYSE:EBS) announced that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent's advanced anthrax vaccine candidates known as dmPA7909. The novel vaccine candidate is designed to have characteristics that will make it ideal to meet the U.S. ...more
02 Oct 2009
Securing Biological Select Agents And Toxins Will Require Developing A Culture Of Trust
The most effective way to prevent the deliberate misuse of biological select agents and toxins (BSATs) - agents housed in laboratories across the U.S. considered to potentially pose a threat to human health - is to instill a culture of trust and responsibility in the laboratory, says a new report from the National Research Council. Focusing on the laboratory environment will be critical for identifying and reducing concerns about facilities or personnel. ...more
01 Oct 2009
Security Of Biological Select Agents And Toxins
A new report from the National Research Council, RESPONSIBLE RESEARCH WITH BIOLOGICAL SELECT AGENTS AND TOXINS, assesses the efficacy of regulations, procedures, and oversight that have been instituted to safeguard against the deliberate misuse of biological select agents and toxins (BSAT) used in research. The report looks at security programs designed to protect against external threats, as well as internal threats from laboratory personnel. ...more
Workshop In Baltimore To Focus On News And Terrorism: Communicating In A Crisis
This workshop will focus on effectively communicating information during a terrorism attack. Journalists, government officials, emergency managers, science/engineering/health experts, and others will participate in a tabletop terrorism scenario exercise designed specifically for Baltimore. This will be the 17th such workshop in a nationwide series and the first during the Obama administration. The project is a joint effort of the National Academy of Engineering, the U.S. ...more
18 Sept 2009
Advanced Life Sciences Announces Restanza(TM) Granted FDA Orphan Drug Designation For Plague And Tularemia
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification. ...more
16 Sept 2009
Psychological Growth From 'Ground Zero-Scale' Trauma
People who live through an extreme traumatic experience such as the 9/11 terrorist attacks or an airplane crash often have the capacity to bounce back or even grow to a higher level of functioning and personal strength, according to a University at Buffalo researcher and expert in the effects of horrifying trauma. ...more
12 Sept 2009
Plastic Surgeons Should Be Part Of Disaster Relief Planning, Response
When a terrorist bomb explodes, a tornado rips through a town, a hurricane devastates a region, or wildfires ravage homes and businesses, plastic surgeons are not typically atop the list of emergency responders. But they should be, UT Southwestern Medical Center plastic surgeons and disaster experts recommend in the September issue of Plastic and Reconstructive Surgery. ...more
12 Sept 2009
New NIST Trace Explosives Standard Slated For Homeland Security Duty
Security personnel need to be able to find explosive materials and persons who have been in contact with them. To aid such searches, the National Institute of Standards and Technology (NIST), with support from the Department of Homeland Security, has developed a new certified reference material, Standard Reference Material (SRM) 2905, Trace Particulate Explosives. ...more
11 Sept 2009
Prototype NIST Method Detects And Measures Elusive Hazards
A chemist at the National Institute of Standards and Technology (NIST) has demonstrated a relatively simple, inexpensive method for detecting and measuring elusive hazards such as concealed explosives and toxins, invisible spoilage in food or pesticides distributed in soil by wind and rain. ...more
11 Sept 2009
Improving Immune Defense Against Anthrax
Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare. Spread of the deadly disease anthrax by spores of the bacterium Bacillus anthracis is a known terrorism risk and protection includes finding ways to treat the disease, according to an academic paper reviewed by Faculty of 1000. Scientists from the University of California (San Diego) have identified a gene in B. ...more